StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 781.00
+1.00 (0.13%)
Dec 15, 2025, 3:01 PM JST
StemCell Institute Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
| 2,721 | 2,679 | 2,481 | 2,091 | 1,781 | 1,409 | Upgrade | |
Revenue Growth (YoY) | 3.03% | 7.98% | 18.65% | 17.41% | 26.40% | -15.93% | Upgrade |
Cost of Revenue | 1,038 | 987 | 905 | 755 | 670 | 485 | Upgrade |
Gross Profit | 1,683 | 1,692 | 1,576 | 1,336 | 1,111 | 924 | Upgrade |
Selling, General & Admin | 1,368 | 1,250 | 1,142 | 1,024 | 874 | 829 | Upgrade |
Operating Expenses | 1,391 | 1,273 | 1,162 | 1,038 | 884 | 837 | Upgrade |
Operating Income | 292 | 419 | 414 | 298 | 227 | 87 | Upgrade |
Interest Expense | -3 | -1 | - | - | - | - | Upgrade |
Interest & Investment Income | 17 | 10 | 3 | 1 | - | - | Upgrade |
Other Non Operating Income (Expenses) | -6 | - | -1 | - | -16 | 4 | Upgrade |
EBT Excluding Unusual Items | 300 | 428 | 416 | 299 | 211 | 91 | Upgrade |
Gain (Loss) on Sale of Investments | - | 136 | 22 | - | - | - | Upgrade |
Other Unusual Items | - | - | 2 | -21 | - | - | Upgrade |
Pretax Income | 300 | 564 | 440 | 278 | 211 | 91 | Upgrade |
Income Tax Expense | 102 | 179 | 130 | 80 | 78 | 29 | Upgrade |
Net Income | 198 | 385 | 310 | 198 | 133 | 62 | Upgrade |
Net Income to Common | 198 | 385 | 310 | 198 | 133 | 62 | Upgrade |
Net Income Growth | -53.08% | 24.19% | 56.57% | 48.87% | 114.52% | -77.62% | Upgrade |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 5 | 5 | Upgrade |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 5 | 5 | Upgrade |
Shares Change (YoY) | -0.63% | -0.05% | - | 102.33% | 4.05% | - | Upgrade |
EPS (Basic) | 19.45 | 37.59 | 30.25 | 19.32 | 26.26 | 12.74 | Upgrade |
EPS (Diluted) | 19.45 | 37.59 | 30.25 | 19.32 | 26.26 | 12.74 | Upgrade |
EPS Growth | -52.78% | 24.25% | 56.57% | -26.42% | 106.16% | -77.62% | Upgrade |
Free Cash Flow | -339 | -11 | 151 | 43 | 288 | -164 | Upgrade |
Free Cash Flow Per Share | -33.29 | -1.07 | 14.74 | 4.20 | 56.87 | -33.70 | Upgrade |
Gross Margin | 61.85% | 63.16% | 63.52% | 63.89% | 62.38% | 65.58% | Upgrade |
Operating Margin | 10.73% | 15.64% | 16.69% | 14.25% | 12.75% | 6.17% | Upgrade |
Profit Margin | 7.28% | 14.37% | 12.50% | 9.47% | 7.47% | 4.40% | Upgrade |
Free Cash Flow Margin | -12.46% | -0.41% | 6.09% | 2.06% | 16.17% | -11.64% | Upgrade |
EBITDA | 431 | 547 | 534 | 402 | 323 | 119 | Upgrade |
EBITDA Margin | 15.84% | 20.42% | 21.52% | 19.23% | 18.14% | 8.45% | Upgrade |
D&A For EBITDA | 139 | 128 | 120 | 104 | 96 | 32 | Upgrade |
EBIT | 292 | 419 | 414 | 298 | 227 | 87 | Upgrade |
EBIT Margin | 10.73% | 15.64% | 16.69% | 14.25% | 12.75% | 6.17% | Upgrade |
Effective Tax Rate | 34.00% | 31.74% | 29.54% | 28.78% | 36.97% | 31.87% | Upgrade |
Advertising Expenses | - | 221 | 196 | 194 | 175 | 166 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.